Abalonyx is a cleantech SME with focus on graphene and graphene derivatives for use in water-treatment and nanostructured, biomimetic functional materials. The company has developed a proprietary process for production of graphene oxide.
As the recognized global leader in power technologies, ABB is conducting research in nanotechnologies. For instance, ABB is perfecting a nano-structured sliding bearing that works in MV and HV switchgear without oil, offering lower operating costs and less environmental impact.
Serendip develops solutions and processes that combine advanced technology with environmental compatibility, providing high added value for manufacturers of creams, gels, lotions and ointments in the life sciences sector.
With expertise in advanced materials R&D, technology and software development, and industrial process development, Accelergy is providing research and development capabilities and the process of advanced materials commercialization for the energy markets.
Accium offers laboratory services based on its Accelerator Mass Spectrometry platform used to detect 14C/12C ratios which provided 1,000 times more sensitivity than the most sensitive method available today such as LC/MS. It is now possible to trace biomolecule delivery in healthy subjects with low attomole sensitivity.
Acreo provides contract R&D services in electronics, optics and communication technologies. The companies competencies include advance nanoscale fabrication technologies such as nanoimprint lithography.
Develops in-vitro models of cell and tissue systems. They simulate the transport of substances and formulations across biological barriers, from which conclusions regarding permeability and absorption can be drawn.
Aculon specializes in inventing and commercializing unique molecular-scale surface and interfacial coatings leveraging nanotechnology discoveries made at Princeton University. From electronic device and component manufacturing to industrial metal finishing to consumer appliances and electronics, Aculon adds value through nano-scale surface modification that delivers superior performance, process simplification and favorable economics.
The company has developed a proprietary formulation technology called HDDS that converts drugs that do not dissolve well in water, or hydrophobic drugs, into microparticles or nanoparticles of the drug embedded in small microspheres, such that the drug can more rapidly dissolve in water.